VivoSeq
Other

Acute

1

Pipeline Programs

11

Active Trials

18

Companies Involved

Acute is an early-stage landscape with 1 program across 18 companies. The most active players are Eli Lilly, Boehringer Ingelheim, AbbVie.

Pipeline Metrics

Competitive Density

30/100

Pipeline Velocity

22/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

13/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 3
No programs
Approved
No programs

Trial Status

110

clinical trials

Completed68 · 62%
Unknown status17 · 15%
Terminated9 · 8%
Recruiting7 · 6%
Withdrawn5 · 5%
Not yet recruiting2 · 2%
Other2 · 2%

Trial Activity

110 trials

BPC 157 for Acute Hamstring Muscle Strain Repair
Recruiting·HHudson Biotech·Phase 2·NCT07437547·120 enrolled
Acute Effects of Oral Nicotine Pouches
Recruiting·JJohns Hopkins University·Phase 1·NCT07128329·120 enrolled
Does Allopurinol Prolong a Treated, Acute Gout Flare?
Completed·559th Medical Wing·Phase 4·NCT01988402·35 enrolled
Page 1 of 8

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)